Latest filing published 09 Sept 2026 for BELITE BIO, INC, €409k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Yu-Hsin Lin in Belite Bio, Inc. In total, 26 filings cover trades dated from 9 April 2026 to 8 September 2026.
No open-market purchase appears, only 25 sales worth €17.9M.
The newest entry dates from 9 September 2026: an open-market sale of €409k, in Belite Bio, Inc. The median gap between a trade and its publication by SEC (Form 4) is 5 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 26 declarations